{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:10:55Z","timestamp":1782792655223,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004484","name":"tehran university of medical sciences and health services","doi-asserted-by":"publisher","award":["98-02-30-40382"],"award-info":[{"award-number":["98-02-30-40382"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-021-02294-z","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T12:02:42Z","timestamp":1635336162000},"page":"791-797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A split-face comparison of fractional erbium: YAG laser plus Kligman\u2019s formula vs. Kligman\u2019s formula monotherapy for facial melasma"],"prefix":"10.1007","volume":"314","author":[{"given":"Maryam","family":"Nasimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghiasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahideh","family":"Lajevardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6790-7633","authenticated-orcid":false,"given":"Safoura","family":"Shakoei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"issue":"3","key":"2294_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1473-2165.2007.00321.x","volume":"6","author":"D Rigopoulos","year":"2007","unstructured":"Rigopoulos D, Gregoriou S, Katsambas A (2007) Hyperpigmentation and melasma. J Cosmet Dermatol 6(3):195\u2013202. https:\/\/doi.org\/10.1111\/j.1473-2165.2007.00321.x (PubMed PMID: 17760699)","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"2294_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1365-2133.2003.05419.x","volume":"149","author":"R Balkrishnan","year":"2003","unstructured":"Balkrishnan R, McMichael AJ, Camacho FT et al (2003) Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 149(3):572\u2013577. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05419.x (PubMed PMID: 14510991)","journal-title":"Br J Dermatol"},{"issue":"7 Pt 1","key":"2294_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1524-4725.2012.02435.x","volume":"38","author":"KL Ball Arefiev","year":"2012","unstructured":"Ball Arefiev KL, Hantash BM (2012) Advances in the treatment of melasma: a review of the recent literature. Dermatol Surg Off Publ Am Soc Dermatol Surg 38(7 Pt 1):971\u2013984. https:\/\/doi.org\/10.1111\/j.1524-4725.2012.02435.x (PubMed PMID: 22583339)","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg"},{"issue":"2","key":"2294_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.det.2005.01.001","volume":"23","author":"JP Ortonne","year":"2005","unstructured":"Ortonne JP, Passeron T (2005) Melanin pigmentary disorders: treatment update. Dermatol Clin 23(2):209\u2013226. https:\/\/doi.org\/10.1016\/j.det.2005.01.001 (PubMed PMID: 15837152)","journal-title":"Dermatol Clin"},{"issue":"2","key":"2294_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1590\/s0365-05962013000200009","volume":"88","author":"OO Morais","year":"2013","unstructured":"Morais OO, Lemos \u00c9F, Sousa MC et al (2013) The use of ablative lasers in the treatment of facial melasma. An Bras Dermatol 88(2):238\u2013242. https:\/\/doi.org\/10.1590\/s0365-05962013000200009 (PubMedPMID:23739704;PubMedCentralPMCID:PMCPMC3750887)","journal-title":"An Bras Dermatol"},{"key":"2294_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/ccid.s147413","volume":"11","author":"AM Badawi","year":"2018","unstructured":"Badawi AM, Osman MA (2018) Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma. Clin Cosmet Investig Dermatol 11:13\u201320. https:\/\/doi.org\/10.2147\/ccid.s147413 (PubMedPMID:29379308;PubMedCentralPMCID:PMCPMC5757209)","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"2294_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/ijd.12477","volume":"54","author":"E Attwa","year":"2015","unstructured":"Attwa E, Khater M, Assaf M et al (2015) Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study. Int J Dermatol 54(2):235\u2013244. https:\/\/doi.org\/10.1111\/ijd.12477 (PubMed PMID: 25266556)","journal-title":"Int J Dermatol"},{"issue":"1","key":"2294_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15171\/jlms.2017.01","volume":"8","author":"S Alavi","year":"2017","unstructured":"Alavi S, Abolhasani E, Asadi S et al (2017) Combination of Q-switched Nd:YAG and fractional erbium:YAG lasers in treatment of melasma: a randomized controlled clinical trial. J Lasers Med Sci 8(1):1\u20136. https:\/\/doi.org\/10.15171\/jlms.2017.01 (PubMed PMID: 28912936; PubMed Central PMCID: PMCPMC5420358)","journal-title":"J Lasers Med Sci"},{"issue":"2","key":"2294_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/jocd.12751","volume":"18","author":"H Abdel-Raouf Mohamed","year":"2019","unstructured":"Abdel-Raouf Mohamed H, Ali Nasif G, Saad Abdel-Azim E et al (2019) Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma. J Cosmet Dermatol 18(2):517\u2013523. https:\/\/doi.org\/10.1111\/jocd.12751 (PubMed PMID: 30146730)","journal-title":"J Cosmet Dermatol"},{"key":"2294_CR10","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1097\/dss.0000000000000207","volume":"40","author":"AM Erlendsson","year":"2014","unstructured":"Erlendsson AM, Anderson RR, Manstein D et al (2014) Developing technology: ablative fractional lasers enhance topical drug delivery. Dermatol Surg Off Publ Am Soc Dermatol Surg 40:S142\u2013S146. https:\/\/doi.org\/10.1097\/dss.0000000000000207 (PubMed PMID: 25417565)","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg"},{"issue":"5","key":"2294_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/lsm.20048","volume":"34","author":"D Manstein","year":"2004","unstructured":"Manstein D, Herron GS, Sink RK et al (2004) Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 34(5):426\u2013438. https:\/\/doi.org\/10.1002\/lsm.20048 (PubMed PMID: 15216537)","journal-title":"Lasers Surg Med"},{"issue":"1","key":"2294_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jaad.2009.10.051","volume":"64","author":"AG Pandya","year":"2011","unstructured":"Pandya AG, Hynan LS, Bhore R et al (2011) Reliability assessment and validation of the melasma area and severity index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol 64(1):78\u201383. https:\/\/doi.org\/10.1016\/j.jaad.2009.10.051 (PubMed PMID: 20398960)","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2294_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-4362.1988.tb02329.x","volume":"27","author":"M V\u00e1zquez","year":"1988","unstructured":"V\u00e1zquez M, Maldonado H, Benmam\u00e1n C et al (1988) Melasma in men. A clinical and histologic study. Int J Dermatol 27(1):25\u201327. https:\/\/doi.org\/10.1111\/j.1365-4362.1988.tb02329.x (PubMed PMID: 3346120)","journal-title":"Int J Dermatol"},{"issue":"12","key":"2294_CR14","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2310\/6350.2005.31302","volume":"31","author":"CK Rokhsar","year":"2005","unstructured":"Rokhsar CK, Fitzpatrick RE (2005) The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg Off Publ Am Soc Dermatol Surg 31(12):1645\u20131650. https:\/\/doi.org\/10.2310\/6350.2005.31302 (PubMed PMID: 16336881)","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg"},{"issue":"3","key":"2294_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/14764172.2013.769274","volume":"15","author":"HS Kim","year":"2013","unstructured":"Kim HS, Kim EK, Jung KE et al (2013) A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin. J Cosmetic Laser Ther Off Publ Eur Soc Laser Dermatol 15(3):143\u2013149. https:\/\/doi.org\/10.3109\/14764172.2013.769274 (PubMed PMID: 23607714)","journal-title":"J Cosmetic Laser Ther Off Publ Eur Soc Laser Dermatol"},{"issue":"1","key":"2294_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10103-009-0734-8","volume":"25","author":"I BogdanAllemann","year":"2010","unstructured":"BogdanAllemann I, Kaufman J (2010) Fractional photothermolysis\u2013an update. Lasers Med Sci 25(1):137\u2013144. https:\/\/doi.org\/10.1007\/s10103-009-0734-8 (PubMed PMID: 19787413)","journal-title":"Lasers Med Sci"},{"issue":"1","key":"2294_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.15171\/jlms.2020.12","volume":"11","author":"N Namazi","year":"2020","unstructured":"Namazi N, Hesami A, Ketabi Y (2020) The split-face comparison of the combined Er-YAG laser and hydroquinone 4% with hydroquinone 4% alone in the treatment of melasma in iranian patients: a prospective, interventional case study. J Lasers Med Sci 11(1):70\u201373. https:\/\/doi.org\/10.15171\/jlms.2020.12 (PubMed PMID: 32099630; PubMed Central PMCID: PMCPMC7008736)","journal-title":"J Lasers Med Sci"},{"key":"2294_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2020.1771259","volume":"18","author":"S Otb","year":"2020","unstructured":"Otb S, Shaarawy E, Sadek A et al (2020) A split face comparative study between intradermal tranexamic acid and erbium-YAG laser in treatment of melasma. J Dermatolog Treat 18:1\u201322. https:\/\/doi.org\/10.1080\/09546634.2020.1771259 (PubMed PMID: 32420770)","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"2294_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1473-2165.2011.00585.x","volume":"10","author":"P Vaiyavatjamai","year":"2011","unstructured":"Vaiyavatjamai P, Wattanakrai P (2011) Side effects and complications of fractional 1550-nm erbium fiber laser treatment among Asians. J Cosmet Dermatol 10(4):313\u2013316. https:\/\/doi.org\/10.1111\/j.1473-2165.2011.00585.x (PubMed PMID: 22151942)","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"2294_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1524-4725.2009.01066.x","volume":"35","author":"R Wanitphakdeedecha","year":"2009","unstructured":"Wanitphakdeedecha R, Manuskiatti W, Siriphukpong S et al (2009) Treatment of melasma using variable square pulse Er:YAG laser resurfacing. Dermatol surg off publ Am Soc Dermatol Surg 35(3):475\u2013481. https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01066.x (PubMed PMID: 19250309)","journal-title":"Dermatol surg off publ Am Soc Dermatol Surg"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02294-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-021-02294-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02294-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T17:10:23Z","timestamp":1661274623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-021-02294-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2294"],"URL":"https:\/\/doi.org\/10.1007\/s00403-021-02294-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Patient consent for publication is achieved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}